Market Overview:
The global fibrinogen reagent kits market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for fibrinogen reagent kits from hospitals & medical centers, clinical laboratories, and academic & research institutes across the globe. Additionally, factors such as technological advancements and rising awareness about various diseases are also contributing to the growth of this market. However, stringent regulatory norms and high costs associated with R&D are restraining the growth of this market to some extent.
Product Definition:
A Fibrinogen Reagent Kit is a medical device that is used to measure the amount of fibrinogen in a patient's blood. Fibrinogen is a protein that helps form clots and stop bleeding. The kit contains reagents and instructions for use. It is used to help diagnose conditions such as thrombophilia, which is a disorder that causes excessive clotting, and disseminated intravascular coagulation (DIC), which is a condition in which blood clots form throughout the body.
Buffer:
The global buffer market is expected to witness significant growth over the forecast period. The primary factor responsible for this growth is increasing demand for advanced reagents in clinical and research laboratories.
In addition, growing awareness among healthcare professionals regarding the benefits of using buffers in laboratory experiments is also anticipated to boost product demand over the coming years.
Antibody:
Antibody is a protein produced by the body in response to an antigen. The most commonly used antibody for diagnostic and research purposes is the immunoglobulin G1 subtype, also known as anti-G1 antibody. It is found in nearly all blood cells and is responsible for initiating immune responses against viruses, bacteria, tumor cells or other foreign substances that enter the body through injury or disease.
Application Insights:
The global demand for fibrinogen reagents has witnessed a paradigm shift due to the development of advanced diagnostic tests. The market is categorized based on application into hospitals & medical centers, clinical laboratories, academic & research institutes and others. Hospitals & medical centers held the largest share in 2017 owing to an increase in trauma cases and rising prevalence of chronic diseases such as cardiovascular disorders, cancer and diabetes mellitus.
Increasing awareness about healthy lifestyle practices among consumers is expected to drive the demand for sports nutrition products that contain fibrinogen over the forecast period. This trend will have a positive impact on product sales in this segment over the next eight years.
Regional Analysis:
North America dominated the global market in 2017 owing to the presence of well-established healthcare infrastructure, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region. Moreover, increasing number of product launches and favorable reimbursement policies are expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising geriatric population base and improving economic conditions that have resulted in an increase in hospital admissions for various disorders including cardiovascular diseases (CVDs). In addition, growing medical tourism industry due to low treatment cost is also expected boost demand for fibrinogen reagents over the coming years.
Growth Factors:
- Increasing incidence of thrombotic disorders: The global prevalence of thrombotic disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and dietary habits, growing aging population, and rising incidence of obesity and diabetes. This is expected to drive the demand for fibrinogen reagent kits in the coming years.
- Technological advancements in fibrinogen testing: The technological advancements in fibrinogen testing are aiding in early diagnosis and treatment of thrombotic disorders. This is resulting in increased demand for fibrinogen reagent kits across the globe.
- Growing awareness about thrombosis: There is a growing awareness among people about the dangers posed by thrombus formation inside blood vessels, which can lead to several life-threatening conditions such as heart attack, stroke, or pulmonary embolism (PE). This is propelling the demand for diagnostic tests for early detection of these conditions, including those that use fibrinogen reagents kits.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fibrinogen Reagent Kits Market Research Report
By Type
Buffer, Antibody
By Application
Hospitals & Medical Centers, Clinical Laboratories, Academic & Research Institutes
By Companies
Fisher Scientific, Helena Laboratories, Werfen, Grifols, Stago, MedTest, Randox, Medirox, Technoclone, Tulip Diagnostics, SEKISUI MEDICAL, Enzyme Research Laboratories, Kamiya Biomedical Company, Pathway Diagnostics, Atlas Medical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Fibrinogen Reagent Kits Market Report Segments:
The global Fibrinogen Reagent Kits market is segmented on the basis of:
Types
Buffer, Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Medical Centers, Clinical Laboratories, Academic & Research Institutes
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fisher Scientific
- Helena Laboratories
- Werfen
- Grifols
- Stago
- MedTest
- Randox
- Medirox
- Technoclone
- Tulip Diagnostics
- SEKISUI MEDICAL
- Enzyme Research Laboratories
- Kamiya Biomedical Company
- Pathway Diagnostics
- Atlas Medical
Highlights of The Fibrinogen Reagent Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Buffer
- Antibody
- By Application:
- Hospitals & Medical Centers
- Clinical Laboratories
- Academic & Research Institutes
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fibrinogen Reagent Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fibrinogen reagent kits are used to determine the amount of fibrinogen in a sample.
Some of the key players operating in the fibrinogen reagent kits market are Fisher Scientific, Helena Laboratories, Werfen, Grifols, Stago, MedTest, Randox, Medirox, Technoclone, Tulip Diagnostics, SEKISUI MEDICAL, Enzyme Research Laboratories, Kamiya Biomedical Company, Pathway Diagnostics, Atlas Medical.
The fibrinogen reagent kits market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fibrinogen Reagent Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fibrinogen Reagent Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fibrinogen Reagent Kits Market - Supply Chain
4.5. Global Fibrinogen Reagent Kits Market Forecast
4.5.1. Fibrinogen Reagent Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fibrinogen Reagent Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fibrinogen Reagent Kits Market Absolute $ Opportunity
5. Global Fibrinogen Reagent Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fibrinogen Reagent Kits Market Size and Volume Forecast by Type
5.3.1. Buffer
5.3.2. Antibody
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fibrinogen Reagent Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fibrinogen Reagent Kits Market Size and Volume Forecast by Application
6.3.1. Hospitals & Medical Centers
6.3.2. Clinical Laboratories
6.3.3. Academic & Research Institutes
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fibrinogen Reagent Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fibrinogen Reagent Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fibrinogen Reagent Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fibrinogen Reagent Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fibrinogen Reagent Kits Demand Share Forecast, 2019-2026
9. North America Fibrinogen Reagent Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fibrinogen Reagent Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fibrinogen Reagent Kits Market Size and Volume Forecast by Application
9.4.1. Hospitals & Medical Centers
9.4.2. Clinical Laboratories
9.4.3. Academic & Research Institutes
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fibrinogen Reagent Kits Market Size and Volume Forecast by Type
9.7.1. Buffer
9.7.2. Antibody
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fibrinogen Reagent Kits Demand Share Forecast, 2019-2026
10. Latin America Fibrinogen Reagent Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fibrinogen Reagent Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fibrinogen Reagent Kits Market Size and Volume Forecast by Application
10.4.1. Hospitals & Medical Centers
10.4.2. Clinical Laboratories
10.4.3. Academic & Research Institutes
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fibrinogen Reagent Kits Market Size and Volume Forecast by Type
10.7.1. Buffer
10.7.2. Antibody
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fibrinogen Reagent Kits Demand Share Forecast, 2019-2026
11. Europe Fibrinogen Reagent Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fibrinogen Reagent Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fibrinogen Reagent Kits Market Size and Volume Forecast by Application
11.4.1. Hospitals & Medical Centers
11.4.2. Clinical Laboratories
11.4.3. Academic & Research Institutes
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fibrinogen Reagent Kits Market Size and Volume Forecast by Type
11.7.1. Buffer
11.7.2. Antibody
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fibrinogen Reagent Kits Demand Share, 2019-2026
12. Asia Pacific Fibrinogen Reagent Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fibrinogen Reagent Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fibrinogen Reagent Kits Market Size and Volume Forecast by Application
12.4.1. Hospitals & Medical Centers
12.4.2. Clinical Laboratories
12.4.3. Academic & Research Institutes
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fibrinogen Reagent Kits Market Size and Volume Forecast by Type
12.7.1. Buffer
12.7.2. Antibody
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fibrinogen Reagent Kits Demand Share, 2019-2026
13. Middle East & Africa Fibrinogen Reagent Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fibrinogen Reagent Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fibrinogen Reagent Kits Market Size and Volume Forecast by Application
13.4.1. Hospitals & Medical Centers
13.4.2. Clinical Laboratories
13.4.3. Academic & Research Institutes
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fibrinogen Reagent Kits Market Size and Volume Forecast by Type
13.7.1. Buffer
13.7.2. Antibody
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fibrinogen Reagent Kits Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fibrinogen Reagent Kits Market: Market Share Analysis
14.2. Fibrinogen Reagent Kits Distributors and Customers
14.3. Fibrinogen Reagent Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Fisher Scientific
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Helena Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Werfen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Grifols
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Stago
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MedTest
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Randox
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medirox
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Technoclone
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Tulip Diagnostics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. SEKISUI MEDICAL
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Enzyme Research Laboratories
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Kamiya Biomedical Company
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Pathway Diagnostics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Atlas Medical
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
